Scientists worry finalizing ‘Schedule F’ rule will further politicize NIH grant decisions
Stat News • 2/6/2026 – 2/7/2026
Summary
The Trump administration is advancing a personnel rule known as 'Schedule F.' Critics express concern that this rule will increase political pressure on a wider range of the federal workforce, particularly affecting decisions related to NIH grants.
Advertisement
Lindy Score Breakdown (V4.2)
56d
Age
1
Sources
from cluster
1338
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1338/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1338/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 56 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk
Stat News • 2 days ago
STAT reporter goes up against radiologists to spot deepfake X-rays
Stat News • 1 day ago
Supreme Court conversion therapy decision could ripple through medicine
Stat News • Today
Supreme Court rules against conversion therapy ban
Stat News • 2 days ago
CDC stops testing for rabies, pox viruses
Stat News • 1 day ago
STAT+: ‘Takeover Tuesday’ saves biotech’s quarter
Stat News • 1 day ago
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News • 1 day ago
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 2 days ago
STAT+: Makary marks one year at FDA with focus on achievements in speech to staff
Stat News • 2 days ago
STAT+: Large AI scribe study finds modest time savings, inconsistent use
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 4 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago